Creative Medical Technology Net Income
| CELZ Stock | USD 1.97 0.03 1.50% |
As of the 5th of February, Creative Medical shows the mean deviation of 3.94, and Risk Adjusted Performance of (0.08). Creative Medical Tec technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Creative Medical Total Revenue |
|
Gross Profit | Quarterly Earnings Growth 3.589 | Market Capitalization | Enterprise Value Revenue 268.9708 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -4.9 M | -5.2 M | |
| Net Loss | -4.9 M | -5.2 M | |
| Net Income Applicable To Common Shares | 17.3 M | 18.2 M | |
| Net Loss | (4.27) | (4.48) | |
| Net Income Per E B T | 1.18 | 1.65 |
Creative | Net Income | Build AI portfolio with Creative Stock |
The evolution of Net Income for Creative Medical Technology provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Creative Medical compares to historical norms and industry peers.
Latest Creative Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Creative Medical Technology over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Creative Medical Tec financial statement analysis. It represents the amount of money remaining after all of Creative Medical Technology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Creative Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Creative Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (5.49 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Creative Net Income Regression Statistics
| Arithmetic Mean | (4,345,404) | |
| Coefficient Of Variation | (247.20) | |
| Mean Deviation | 6,442,459 | |
| Median | (2,659,108) | |
| Standard Deviation | 10,741,696 | |
| Sample Variance | 115.4T | |
| Range | 55.5M | |
| R-Value | (0.22) | |
| Mean Square Error | 116.9T | |
| R-Squared | 0.05 | |
| Significance | 0.39 | |
| Slope | (477,366) | |
| Total Sum of Squares | 1846.1T |
Creative Net Income History
Other Fundumenentals of Creative Medical Tec
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Creative Medical Net Income component correlations
Creative Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Creative Medical is extremely important. It helps to project a fair market value of Creative Stock properly, considering its historical fundamentals such as Net Income. Since Creative Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Creative Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Creative Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Creative Medical. Projected growth potential of Creative fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Creative Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 3.589 | Earnings Share (2.84) | Revenue Per Share | Return On Assets | Return On Equity |
The market value of Creative Medical Tec is measured differently than its book value, which is the value of Creative that is recorded on the company's balance sheet. Investors also form their own opinion of Creative Medical's value that differs from its market value or its book value, called intrinsic value, which is Creative Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Creative Medical's market value can be influenced by many factors that don't directly affect Creative Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Creative Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Creative Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Creative Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Creative Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Creative Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Creative Medical.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Creative Medical on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Creative Medical Technology or generate 0.0% return on investment in Creative Medical over 90 days. Creative Medical is related to or competes with Biocardia, Acurx Pharmaceuticals, Aprea Therapeutics, HCW Biologics, Adial Pharmaceuticals, Alzamend Neuro, and Kiora Pharmaceuticals. Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and ne... More
Creative Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Creative Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Creative Medical Technology upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 23.26 | |||
| Value At Risk | (8.89) | |||
| Potential Upside | 8.61 |
Creative Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Creative Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Creative Medical's standard deviation. In reality, there are many statistical measures that can use Creative Medical historical prices to predict the future Creative Medical's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.72) | |||
| Total Risk Alpha | (1.03) | |||
| Treynor Ratio | (0.46) |
Creative Medical February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.45) | |||
| Mean Deviation | 3.94 | |||
| Coefficient Of Variation | (825.09) | |||
| Standard Deviation | 5.21 | |||
| Variance | 27.16 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.72) | |||
| Total Risk Alpha | (1.03) | |||
| Treynor Ratio | (0.46) | |||
| Maximum Drawdown | 23.26 | |||
| Value At Risk | (8.89) | |||
| Potential Upside | 8.61 | |||
| Skewness | 0.424 | |||
| Kurtosis | 0.7783 |
Creative Medical Tec Backtested Returns
Creative Medical Tec secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11 % return per unit of standard deviation over the last 3 months. Creative Medical Technology exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Creative Medical's mean deviation of 3.94, and Risk Adjusted Performance of (0.08) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.41, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Creative Medical will likely underperform. At this point, Creative Medical Tec has a negative expected return of -0.57%. Please make sure to confirm Creative Medical's market risk adjusted performance, jensen alpha, as well as the relationship between the Jensen Alpha and accumulation distribution , to decide if Creative Medical Tec performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.09 |
Virtually no predictability
Creative Medical Technology has virtually no predictability. Overlapping area represents the amount of predictability between Creative Medical time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Creative Medical Tec price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Creative Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | 0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Creative Medical Technology reported net income of (5.49 Million). This is 101.61% lower than that of the Biotechnology sector and 107.84% lower than that of the Health Care industry. The net income for all United States stocks is 100.96% higher than that of the company.
Creative Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Creative Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Creative Medical could also be used in its relative valuation, which is a method of valuing Creative Medical by comparing valuation metrics of similar companies.Creative Medical is currently under evaluation in net income category among its peers.
Creative Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Creative Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Creative Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Creative Medical's value.| Shares | Td Waterhouse Canada Inc | 2025-06-30 | 1.0 | Org Partners Llc | 2025-06-30 | 0.0 | Armistice Capital, Llc | 2025-06-30 | 0.0 | Hrt Financial Llc | 2025-06-30 | 0.0 | Geode Capital Management, Llc | 2025-06-30 | 20.9 K | Vanguard Group Inc | 2025-06-30 | 17.6 K | Northern Trust Corp | 2025-06-30 | 11.7 K | Citadel Advisors Llc | 2025-06-30 | 11.1 K | Hanson Mcclain Inc | 2025-06-30 | 4 K | Ameritas Advisory Services, Llc | 2025-06-30 | 2.3 K | Advisor Group Holdings, Inc. | 2025-06-30 | 1.1 K |
Creative Fundamentals
| Return On Equity | -0.98 | ||||
| Return On Asset | -0.6 | ||||
| Current Valuation | 1.82 M | ||||
| Shares Outstanding | 3.49 M | ||||
| Shares Owned By Insiders | 1.00 % | ||||
| Shares Owned By Institutions | 5.90 % | ||||
| Number Of Shares Shorted | 361.92 K | ||||
| Price To Earning | (54.81) X | ||||
| Price To Book | 1.25 X | ||||
| Price To Sales | 1,165 X | ||||
| Revenue | 11 K | ||||
| Gross Profit | 3.6 K | ||||
| EBITDA | (5.63 M) | ||||
| Net Income | (5.49 M) | ||||
| Cash And Equivalents | 22.86 M | ||||
| Cash Per Share | 1.62 X | ||||
| Total Debt | 14.19 K | ||||
| Current Ratio | 58.88 X | ||||
| Book Value Per Share | 2.17 X | ||||
| Cash Flow From Operations | (5.3 M) | ||||
| Short Ratio | 2.40 X | ||||
| Earnings Per Share | (2.84) X | ||||
| Target Price | 20.0 | ||||
| Beta | 2.07 | ||||
| Market Capitalization | 6.99 M | ||||
| Total Asset | 6.67 M | ||||
| Retained Earnings | (64.59 M) | ||||
| Working Capital | 5.81 M | ||||
| Net Asset | 6.67 M |
About Creative Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Creative Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Creative Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Creative Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.